Clinical impact of c-KIT and CEBPA mutations in 33 patients with corebinding factor (Non-M3) acute myeloid leukemia

• Autores principales: Xiaoyan Mao (Autor), Runxiu Yin (Autor), Li Liu (Autor), Yan Zhou (Autor), Chunhui Yang (Autor), Chunlian Fang (Autor), Hongchao Jiang (Autor), Qulian Guo (Autor), Xin Tian (Autor)
• Formato: Libro
• Publicado: Elsevier, 2023-07-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Background: Corebinding factor acute myeloid leukemia (CBF-AML) is the most common cytogenetic subtype of pediatric AML. CBF-AML is associated with a relatively favorable outcome, although the relapse rate of approximately 40% indicates a high degree of clinical heterogeneity. The clinical impact of...